101 related articles for article (PubMed ID: 31738034)
1. Ipriflavone inhibits the differentiation of RAW 264.7 cells into osteoclasts via Foxo1.
Sun J; Zhang G; Hu Z
Minerva Endocrinol; 2019 Dec; 44(4):400-402. PubMed ID: 31738034
[No Abstract] [Full Text] [Related]
2. Binding and bioeffects of Ipriflavone on a human preosteoclastic cell line.
Benvenuti S; Petilli M; Frediani U; Tanini A; Fiorelli G; Bianchi S; Bernabei PA; Albanese C; Brandi ML
Biochem Biophys Res Commun; 1994 Jun; 201(3):1084-9. PubMed ID: 7517664
[TBL] [Abstract][Full Text] [Related]
3. Incorporation and effects of mesoporous SiO
Casarrubios L; Gómez-Cerezo N; Feito MJ; Vallet-Regí M; Arcos D; Portolés MT
Eur J Pharm Biopharm; 2018 Dec; 133():258-268. PubMed ID: 30385420
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of ipriflavone on osteoclast-mediated bone resorption and new osteoclast formation in long-term cultures of mouse unfractionated bone cells.
Notoya K; Yoshida K; Taketomi S; Yamazaki I; Kumegawa M
Calcif Tissue Int; 1993 Sep; 53(3):206-9. PubMed ID: 8242474
[TBL] [Abstract][Full Text] [Related]
5. 6,7,4'-Trihydroxyflavone inhibits osteoclast formation and bone resorption in vitro and in vivo.
Kim EN; Kim YG; Lee JH; Min BS; Jeong GS
Phytother Res; 2019 Nov; 33(11):2948-2959. PubMed ID: 31478281
[TBL] [Abstract][Full Text] [Related]
6. Ipriflavone inhibits murine osteoclast formation in vitro.
Morita I; Sakaguchi K; Kurachi T; Murota S
Calcif Tissue Int; 1992; 51 Suppl 1():S7-10. PubMed ID: 1422984
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol prevents osteoporosis by upregulating FoxO1 transcriptional activity.
Feng YL; Jiang XT; Ma FF; Han J; Tang XL
Int J Mol Med; 2018 Jan; 41(1):202-212. PubMed ID: 29115382
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of ipriflavone on pit formation in mouse unfractionated bone cells.
Notoya K; Yoshida K; Taketomi S; Yamazaki I; Kumegawa M
Calcif Tissue Int; 1992; 51 Suppl 1():S3-6. PubMed ID: 1422982
[TBL] [Abstract][Full Text] [Related]
9. Ipriflavone inhibits osteoclast differentiation in parathyroid transplanted parietal bone of rats.
Bonucci E; Ballanti P; Martelli A; Mereto E; Brambilla G; Bianco P; Bufalino L
Calcif Tissue Int; 1992 Apr; 50(4):314-9. PubMed ID: 1571842
[TBL] [Abstract][Full Text] [Related]
10. Ipriflavone directly inhibits osteoclastic activity.
Albanese CV; Cudd A; Argentino L; Zambonin-Zallone A; MacIntyre I
Biochem Biophys Res Commun; 1994 Mar; 199(2):930-6. PubMed ID: 8135842
[TBL] [Abstract][Full Text] [Related]
11. Histochemical and fine structural study of bone of ipriflavone-treated rats.
Ozawa H; Nakamura H; Irie K; Irie M
Calcif Tissue Int; 1992; 51 Suppl 1():S21-6. PubMed ID: 1422980
[TBL] [Abstract][Full Text] [Related]
12. Alpinumisoflavone inhibits osteoclast differentiation and exerts anti-osteoporotic effect in ovariectomized mice.
Cong W; Zhou C; Yin J
Biomed Pharmacother; 2017 Sep; 93():344-351. PubMed ID: 28651235
[TBL] [Abstract][Full Text] [Related]
13. Similarities and differences between the effects of ipriflavone and vitamin K on bone resorption and formation in vitro.
Notoya K; Yoshida K; Shirakawa Y; Taketomi S; Tsuda M
Bone; 1995 Apr; 16(4 Suppl):349S-353S. PubMed ID: 7626324
[TBL] [Abstract][Full Text] [Related]
14. Leucine promotes differentiation of porcine myoblasts through the protein kinase B (Akt)/Forkhead box O1 signalling pathway.
Zhang S; Chen X; Huang Z; Chen D; Yu B; Chen H; Luo J; He J; Zheng P; Yu J
Br J Nutr; 2018 Apr; 119(7):727-733. PubMed ID: 29569540
[TBL] [Abstract][Full Text] [Related]
15. Lack of effect of ipriflavone on osteoclast motility and bone resorption in in vitro and ex vivo studies.
Notoya K; Taketomi S; Tsuda M
Calcif Tissue Int; 1993 Jul; 53(1):71. PubMed ID: 8348388
[No Abstract] [Full Text] [Related]
16. Ipriflavone: new insights into its mechanisms of action on bone remodeling.
Brandi ML; Gennari C
Calcif Tissue Int; 1993 Feb; 52(2):151-2. PubMed ID: 8443693
[No Abstract] [Full Text] [Related]
17. Cytological and ultrastructural investigation on osteoblastic and preosteoclastic cells grown in vitro in the presence of ipriflavone: preliminary results.
Bonucci E; Silvestrini G; Ballanti P; Masi L; Franchi A; Bufalino L; Brandi ML
Bone Miner; 1992 Oct; 19 Suppl 1():S15-25. PubMed ID: 1422316
[TBL] [Abstract][Full Text] [Related]
18. Novel ipriflavone receptors coupled to calcium influx regulate osteoclast differentiation and function.
Miyauchi A; Notoya K; Taketomi S; Takagi Y; Fujii Y; Jinnai K; Takahashi K; Chihara K; Fujita T
Endocrinology; 1996 Aug; 137(8):3544-50. PubMed ID: 8754785
[TBL] [Abstract][Full Text] [Related]
19. [Research progress on forkhead box protein O1 and bone metabolism].
Linjing S; Yingying W; Zhen T; Ping G
Hua Xi Kou Qiang Yi Xue Za Zhi; 2016 Aug; 34(4):429-432. PubMed ID: 28317366
[TBL] [Abstract][Full Text] [Related]
20. Ipriflavone inhibits osteolytic bone metastasis of human breast cancer cells in a nude mouse model.
Iwasaki T; Mukai M; Tsujimura T; Tatsuta M; Nakamura H; Terada N; Akedo H
Int J Cancer; 2002 Aug; 100(4):381-7. PubMed ID: 12115517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
